Rieder, M.; Laumann, R.; Witsch, T.; Schanze, N.; Heger, L.; Olivier, C.B.; von zur Muehlen, C.; Bode, C.; Ahrens, I.; Lother, A.;
et al. Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury. Appl. Sci. 2020, 10, 6379.
https://doi.org/10.3390/app10186379
AMA Style
Rieder M, Laumann R, Witsch T, Schanze N, Heger L, Olivier CB, von zur Muehlen C, Bode C, Ahrens I, Lother A,
et al. Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury. Applied Sciences. 2020; 10(18):6379.
https://doi.org/10.3390/app10186379
Chicago/Turabian Style
Rieder, Marina, Rosmarie Laumann, Thilo Witsch, Nancy Schanze, Lukas Heger, Christoph B. Olivier, Constantin von zur Muehlen, Christoph Bode, Ingo Ahrens, Achim Lother,
and et al. 2020. "Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury" Applied Sciences 10, no. 18: 6379.
https://doi.org/10.3390/app10186379
APA Style
Rieder, M., Laumann, R., Witsch, T., Schanze, N., Heger, L., Olivier, C. B., von zur Muehlen, C., Bode, C., Ahrens, I., Lother, A., Duerschmied, D., & Hortmann, M.
(2020). Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury. Applied Sciences, 10(18), 6379.
https://doi.org/10.3390/app10186379
